BS-OR

N/A

Report date: 2025/06/11 10:30:53
NME

Base Information

Drug NameBS-OR
Drug Alias NameN/A
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic NeoplasmsLiver NeoplasmsStomach Neoplasms +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBensen Pharmaceutical Corp Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsLiver NeoplasmsStomach Neoplasms +[8
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A